Need for novel, innovative strategies for developing antibiotics is becoming a necessity due to an increasing number of rapidly evolving micro-organismal threats.
INTRODUCTION
The fields of antibiotics and medicine are constantly evolving and changing in order to adapt to the threat of micro-organismal disease as well as numerous other medical complications [1, 2] . Ampicillin, a derivative of penicillin, introduced in 1961
has been an effective antibacterial agent against both Gram positive and Gram negative bacteria, remedying numerous bacterial infections and saving countless lives [3] .
Recently, however, a number of microorganisms have developed strong resistance towards ampicillin and other antibiotics negating the antibiotics effectiveness as broad spectrum antibiotics [3] [4] [5] [6] . With this rising threat, the need for antibiotics to be readily transported to the site of drug action has rapidly increased [7, 8] .
Drug carriers are substances designed to aid in the transport of antibiotics throughout the body. With use of drug carriers to transport antibiotics it is far more likely the antibiotics will have greater efficacy, delivery and less toxicity [9] . Drug carriers have several properties giving them advantages over traditional antibiotic prescription alone [2, 10] . In this context, nanoparticles offer distinct advantages as drug carriers. Drug accuracy is possible due to the surface area to volume ratio of the nanoparticle allowing potentially millions of antibiotic molecules to be attached to a single nanoparticle [9, 11] .
The use of nanoparticle based drug carriers can potentially save an exorbitant amount of capital as well as drastically improve the quality of antibiotic administered [9] . Though many elements can be used for nanoparticle synthesis gold nanoparticles (GNPs) are most ideal, due to non-cytotoxicity, stability and biocompatibility in contrast to other metallic nanoparticles such as zinc and silver [11] . Potential drug carrier and target cell delivery capabilities of GNPs make their use as antimicrobial agents highly ideal and sought after [12] [13] [14] . Due to their high stability and small size GNPs possess the ability to extend the biological half life as well as bioavailability of administered antibiotics. This ability effectively decreases the amount of antibiotic required for administration and increases the likelihood of remediation of infectious disease. Being effective drug carriers
GNPs would possess the capabilities mentioned previously of cost effectiveness, accurate drug delivery, and overall antimicrobial efficiency [9] .
To obtain antibiotic conjugated NP, especially GNP, various strategies have been employed. Most of these strategies involve functionalization of GNP using different linkers such as amino acids, glutathione, polyethylene glycol [15, 16] . But sometimes addition of linker may either reduce the efficacy of the antibiotics or may also interfere with the stability of drugs [15] [16] [17] . Recently two different strategies have been shown to fabricate ampicillin conjugated gold nanoparticles without using linkers [18, 19] . Both of these strategies used either citrate or sodium borohydride for the formation of gold nanoparticles. However, a potential toxicity of GNPs produced by citrate method have been demonstrated, moreover the toxicity of sodium borohydride is also evidences [20] [21] [22] . Thus use of above mentioned chemicals for the synthesis of GNPs, not only makes the synthesis process nonecofriendly but also have potential toxicity on human health. To avoid all the disadvantages and potential risk, we have used a novel strategy of completely green synthesis of ampicillin coated gold nanoparticles (Amp-GNP), in single step synthesis without using any linker or hazardous organic solvents.
In continuation of our research efforts centered on the development of innovative gold nanoparticles for use as antimicrobial agents, we report the completely green synthesis of gold nanoparticles (GNPs) individually coated with the antibiotic ampicillin.
GNPs serve as drug carriers which might deliver the antibiotic to targeted locations minimizing the risk of over-dose and potentially revolutionizing medicine [9] . Synthesis of the Amp-GNPs is entirely eco-friendly involving a single-step synthesis method where the ampicillin serves as both the reducing and capping agent within an aqueous medium. Successful synthesis of Amp-GNPs has proven the effectiveness of the antibiotic ampicillin to serve as an efficient reducing agent in the reduction of Au 3+ to Au 0 within medium. The medium used in the synthesis is an aqueous medium. The novel synthesis process we have developed is advantageous over traditional GNP synthesis methods allowing the GNPs to engage in biomedical applications and is a single-step synthesis procedure further improving the GNPs' economical value and efficiency.
MATERIALS AND METHODS

Reagents and material:
Chemicals including KAuCl4/HAuCl4, ampicillin, Lysogeny Broth (LB) agar, 
Characterization of Antibiotic Coated GNPs:
With the use of PerkinElmer's LAMBDA 35 UV/Vis absorption spectra the AmpGNPs were analyzed for their optical properties. JEOL-TEM Transmission electron microscopy (TEM) was used to determine the morphological characteristics of the AmpGNPs. Samples for the TEM images were prepared by placing a 4 µL Amp-GNPs solution onto a 400 mesh size formvar coated copper grid and air drying them for 5 minutes. Excess water was removed using a filter paper wedge. In determination of the Amp-GNPs' elemental properties electron dispersive x-ray spectroscopy (EDS) was conducted using JEOL-JSM-S400 LV with IXRF system. Samples for EDS were placed onto an aluminum stub and allowed to dry in a desiccator before examination.
Antibacterial Activity of Amp-GNPs:
In determination of the Amp-GNPs efficacy as an antibacterial agent, both liquid broth turbidimetry and solid agar plate based assays were employed. These experiments were performed against multiple strains of bacteria representing both Gram-positive such as Staphylococcus epidermidis, Streptococcus bovis and Gram-negative strains such as
Pseudomonas aeruginosa, and Enterobacter aerogenes. In the turbidimetry assay the Amp-GNPs were inoculated with 105 CFU/mL in a series of test tubes containing 4 mL of sterile liquid media. A control was made by inoculating the media with bacterial cells in absence of Amp-GNPs. All tubes were incubated at 37 ºC for 12 hours. After every hour of incubation the optical density (OD) at a wavelength of 600 nm of both the control and all samples was examined and recorded. Any absorbance due to the Amp-GNPs or the medium was autocorrected using a blank of Amp-GNPs dispersed in the medium, in absence of bacterial organism. Following turbidimetry assays solid agar assays were performed [24] .The bacterial suspensions were centrifuged at 4000 rpm, the pellet was resuspended in 500 μL DPBS and spread onto fresh, solid, nutrient rich agar plates (Luria-Bertani agar / tryptic soy agar). The plates were then allowed to incubate for 12 hours at 37 °C during which time the bacterial colonies became visibly populated. The bacterial colonies were then counted for examination of results [25, 26] . The number of colony forming units was established by taking average of counts from three or more independent experiments.
Amp-GNPs Antimicrobial Mechanism Examination:
To determine the mechanism of the Amp-GNPs antibacterial activity, propidium iodide testing was conducted using both Gram-positive and Gram-negative bacterial strains [14, 27] . Propidium iodide is a chemical dye that fluoresces upon interacting and binding with nucleic acids. Notably, propidium iodide is impermeable to an intact, healthy cell wall. Therefore, organismal solutions with intact cell walls will yield a low level of fluorescence while lysed organismal solutions will fluoresce excessively.
Bacterial organisms were cultured in liquid media samples in the presence of Amp-GNPs at minimum inhibitory concentrations, which was determined from turbidimetry and from spread plate assay. Samples were collected and centrifuged at 6000 rpm for 3 minutes and washed twice with PBS saline buffer (pH~ 7.2). These bacterial cells were incubated with 10 mM propidium iodide in a dark environment for 30 minutes at room temperature.
After incubation, the samples were washed using PBS to get rid of any excess, unbound To visualize the morphology of the bacteria after exposure to Amp-GNPs, cross sectional analysis was performed with the aid of TEM. Bacterial cell samples exposed to minimum inhibitory concentrations of Amp-GNPs were collected at different time points and processed for sectioning. Controls were made by inoculating the media with bacteria in absence of Amp-GNPs. All tubes were incubated at 37 ºC for 12 hours. Sample of 1 mL was collected at different time points from the test tubes and centrifuged at 6000 rpm for 3 minutes. All the samples were thoroughly washed with nanopure water and then placed onto Formvar coated 400 mesh size copper grids and observed under JEOL-TEM.
For cross-section analysis, bacterial cell cultures were fixed using 16 % w/v paraformaldehyde and 10 % w/v gluteraldehydeas primary fixing agents in 50 mM sodium cacodylatebuffer (pH ~ 7.4) and incubated for 2 hours in the hood. The fixed samples were washed thoroughly using the buffer solution and post fixed using 1 % osmium tetroxide (OsO4) and incubated for 1 hour at room temperature. The post-fixed samples were then thoroughly washed with nanopure water followed by the treatment of graded ethanol series (25, 50,75, 95 and 100 %) for 5-10 minutes. The dehydrated samples were further infiltrated by incubation in a graded series of Spur's epoxy resin (33, 66 , 95 and 100 %) for 1 hour and left overnight in a fresh 100 % resin. The samples were centrifuged through fresh resin in BEEM capsules and hardened at 70 °C for 18
hours. Ultra-thin sections of the pelleted samples were cut on an RMC MT-X ultramicrotome using glass knife. Sections were stained with 2 % aqueous uranyl acetate and
Reynold's lead citrate for 15 minutes and 3 minutes respectively and examined using a JEOL-100CX TEM. 
Antibacterial Activity of Amp-GNPs:
In assessment of the Amp-GNPs antimicrobial activity bacterial assays were Additional antimicrobial tests were performed using just the antibiotic ampicillin.
Spread plate assays against the same organisms tested against Amp-GNPs were used.
Results from the experiment illustrated the effectiveness of ampicillin against these strains, " Supplementary Figure 2A , B, C" and the MIC of ampicillin against
Enterobacter aerogenes was determined to be ~2.3 mg/mL, for Pseudomonas aeruginosa was ~1.9 mg/mL, for Staphylococcus epidermidis was ~1.5 mg/mL, and for
Streptococcus bovis was ~1.4 mg/mL respectively, as shown in " Table 1 ".
Figure 2.
A. Growth curve of Staphylococcus epidermidis when exposed to various concentrations of Amp-GNPs. From top to bottom the concentrations are 0.008 mg/mL, 0.016 mg/mL, 0.033 mg/mL, 0.067 mg/mL, 0.08 mg/mL, 0.096 mg/mL, and 0.133 mg/mL. Minimum inhibitory concentration (MIC) was determined to be ~ 0.130 mg/mL. B. Growth curve of Enterobacter aerogenes when exposed to various concentrations of Amp-GNPs. From top to bottom the concentrations are 0.016 mg/mL, 0.033 mg/mL, 0.067 mg/mL, 0.133 mg/mL, 0.256 mg/mL, and 0.512 mg/mL. Minimum inhibitory concentration (MIC) was determined to be ~ 0.500 mg/mL. 
Amp-GNPs Antimicrobial Mechanism Examination:
To determine the mechanism of the Amp-GNPs antibacterial activity, propidium iodide testing was conducted using both Gram-positive and Gram-negative bacterial 
Synthesis and Characterization of Antibiotic Coated GNPs
The objective was to synthesize antibiotic encapsulated GNPs that possess uniformity in both shape and size while still producing a yield of reasonable measure.
The observed color change of the antibiotic encapsulated GNPs was from an approximately clear solution to darker shades of violet. Change in color denotes the formation of GNPs by reduction of gold (Au 3+ to Au 0 ) and hence the formation of the antibiotic ampicillin encapsulated gold nanoparticles [23] . The reduction of the gold ions was possible due to the number of reducing groups such as hydroxyl or amino groups on the ampicillin molecule.
To examine the morphological, optical, and elemental properties of the AmpGNPs a variety of instruments were employed. The UV-Vis experiments on the AmpGNPs the maximum absorbance (λ max) value at 540 nm, the wavelength within the range of absorbance characteristic for GNPs, due to GNPs unique surface plasmon resonance [28, 29] . It is the unique surface plasmon resonance of GNPs that allows this characterization to elucidate the approximate size of ~15 nm and spherical shape of 
Antibacterial Activity of Amp-GNPs
As a β-lactam antibiotic, ampicillin's mechanism of action against bacteria is through the binding of Penicillin Binding Proteins (PBPs) [30] . This binding in turn prevents the formation of the bacterial cell wall.
Without the capability to form a cell wall the organism and subsequent infection will subside. However, some bacterial strains have begun to form resistances towards ampicillin [3] . Through the enzyme beta lactamase which breaks down ampicillin, these evolved strains are capable of evading the ampicillin mechanism of antimicrobial action.
In determination of the Amp-GNPs efficacy as an antibacterial agent, both liquid broth and solid agar plate based assays were employed. These experiments were performed against multiple strains of both Gram- 
Amp-GNP Antimicrobial Mechanism Examination
In assessment of the antimicrobial mechanism of Amp-GNPs the fluorescence microscopy experiments using propidium iodide were performed. Propidium iodide is a chemical dye that fluoresces upon interacting and binding with nucleic acids [14, 26] .
Notably, propidium iodide is impermeable to an intact, healthy cell wall. Therefore, organismal solutions with intact cell walls will yield a low level of fluorescence while Therefore, antibiotic encapsulated GNPs possess a truly unique and potentially revolutionary mechanism of bactericidal action that has the capabilities of transforming the age-old practice of fighting bacterial disease [40] [41] [42] .
CONCLUSION
In conclusion, we report the successful synthesis of antibiotic encapsulated gold nanoparticles using environmentally friendly methods with the antibiotic ampicillin. In 
Supplementary Figure 2. Spread plate assay for (A) Staphylococcus epidermidis, (B)
Streptococcus bovis, (C) Pseudomonas aeruginosa, and (D) Enterobacter aerogenes using ampicillin. Images of plates show untreated control plate followed by ampicillin treated plate for all three strains. Graph shows the number of bacterial colonies versus control (untreated sample) and the MIC of ampicillin. Data confirms MIC of ampicillin against the various strains as being higher than the MIC of AMP-GNPs supporting the idea of AMP-GNPs being more potent and efficient than the standard antibiotic ampicillin.
